CIK 0001420565 · Non-accelerated filer<br>Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 134196017
- Phone
- 7378021989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-16 | Vukovic Vojo SVP, Chief Medical Officer | Purchase | +75,000 | $0.59 | $44K | 75,000 |
| 2019-08-13 | Gregory Kathryn SVP, Chief Business Officer | Purchase | +45,000 | $0.65 | $29K | 45,000 |
| 2019-06-19 | VON RICKENBACH JOSEF H Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2019-06-19 | MCKEE WILLIAM Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2019-06-19 | MCARTHUR JOHN H Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2019-06-19 | Sigal Nolan Howard Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2019-06-19 | Morrison Jodie Pope Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2019-06-19 | Ambros Reinhard J. Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-06-19 | Bailey Jeffrey Allen Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-04-15 | Wanstall Rick VP, Finance and Operations | Grant or award · Stock Option (right to buy) | +59,000 | 59,000 | ||
| 2019-04-15 | Dougherty Donald SVP & Chief Financial Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2019-04-15 | Vukovic Vojo SVP, Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-04-15 | Aivado Manuel President and CEO | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2019-04-15 | Annis Allen SVP, Research | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-04-15 | Gregory Kathryn SVP, Chief Business Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2019-04-02 | Sigal Nolan Howard Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2019-04-01 | Novartis Bioventures Ltd 10% owner | Sale | −20,610 | $1.90 | $39K | 2,079,394 |
| 2019-03-29 | Novartis Bioventures Ltd 10% owner | Sale | −106,540 | $1.85 | $197K | 2,100,004 |
| 2019-03-15 | Novartis Bioventures Ltd 10% owner | Sale | −43,800 | $1.92 | $84K | 2,206,544 |
| 2019-03-14 | Novartis Bioventures Ltd 10% owner | Sale | −13,800 | $1.88 | $26K | 2,250,344 |
Page 8 of 10 · 192 trades